Human insulin biosimilar (MJ Biopharm)

人胰岛素生物类似药 (MJ Biopharm)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman insulin biosimilar (MJ Biopharm)
Drug Alias Name人胰岛素生物仿制药 (MJ Biopharm)Biosulin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2005/12/01
Country/TerritoryRussian FederationIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMj Biopharm Pvt
China Registration ClassN/A

Develop Information

Active CompaniesMj Biopharm Pvt
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A